Biotech company receives €12m for antibiotic alternative
Dutch biotech company, Micreos, announced yesterday that it has secured €12 million in funding for the clinical development of its antibacterial lysin technology, Staphefekt.
Archives for February 19, 2016
Biopharma CEO confidence levels wavering
While Bioparma CEOs remain confident in the industry as a whole, uncertainties still abound.
Cell Therapy Manufacturing & Gene Therapy Congress - Brussels, Belgium
Short shelf-life poses problems for cell therapy makers, Chiesi
The shelf life of a cell therapy product is crucial in determining a firm’s manufacturing strategy according to the makers of the first approved stem-cell based drug.
Brought together by conjugation: CMC Biologics A/S and IDT Biologika form ADC pact
CMC Biologics A/S and IDT Biologika GmbH have teamed up to offer drugmakers an antibody drug conjugate manufacturing service.